Study of CS-7017 in Combination With FOLFIRI in Subjects With Metastatic Colorectal Cancer Who Failed First-Line Therapy
| Status: | Archived |
|---|---|
| Conditions: | Colorectal Cancer, Cancer, Cancer |
| Therapuetic Areas: | Oncology |
| Healthy: | No |
| Age Range: | Any |
| Updated: | 7/1/2011 |
| Start Date: | September 2009 |
| End Date: | October 2011 |
Randomized, Active-Controlled, Open-Label Phase 2 Study of CS-7017 in Combination With FOLFIRI in Subjects With Metastatic Colorectal Cancer Who Failed First-Line Therapy
This phase 2, randomized, active-controlled, open-label, parallel group, multicenter study
will be conducted at up to 18 study centers in the US, Central America, and South America.
Adult subjects with metastatic colorectal cancer (CRC) who failed first-line chemotherapy
will participate in the study, which will be conducted on an outpatient basis. It is
anticipated that 100 subjects will be enrolled to obtain approximately 90 evaluable
subjects.
We found this trial at
6
sites
Click here to add this to my saved trials
4000 Reservoir Road NW, Suite 120
Washington, Washington DC 20007
Washington, Washington DC 20007
(202) 687-0100
Georgetown Univ Med Ctr Georgetown University Medical Center is committed to excellence in research, education...
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials